Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis-Reference-Cited by-同舟云学术

Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis

Published:2009-03 Issue:3 Volume:60 Page:686-697
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Miller Mary-Clare,Manning Hugh B.,Jain Abhilash,Troeberg Linda,Dudhia Jayesh,Essex David,Sandison Ann,Seiki Motoharu,Nanchahal Jagdeep,Nagase Hideaki,Itoh Yoshifumi

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference57 articles.

1. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?;Murphy;Nat Clin Pract Rheumatol,2008

2. Aggrecanases and cartilage matrix degradation;Nagase;Arthritis Res Ther,2003

3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry;Visse;Circ Res,2003

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis;Heliyon;2024-03

2. The therapeutic effects of gingival mesenchymal stem cells and their exosomes in a chimeric model of rheumatoid arthritis;Arthritis Research & Therapy;2023-10-26

3. Global research hotspots and frontier trends of epigenetic modifications in autoimmune diseases: A bibliometric analysis from 2012 to 2022;Medicine;2023-09-29

4. Potential Therapeutic Targets of Resveratrol in the Prevention and Treatment of Pulmonary Fibrosis;Frontiers in Bioscience-Landmark;2023-09-14

5. CCR2 antagonist represses fibroblast-like synoviocyte-mediated inflammation in patients with rheumatoid arthritis;International Immunopharmacology;2023-09